Language
English
Publication Date
6-1-2024
Journal
Cureus
DOI
10.7759/cureus.63239
PMID
39070428
PMCID
PMC11281858
PubMedCentral® Posted Date
6-26-2024
PubMedCentral® Full Text Version
Post-print
Abstract
Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis is a rare form of autoimmune encephalitis. We report a case of a patient with myasthenia gravis post-thymoma treatment who presented with deteriorating mental status. She was found to have positive AMPA receptor titers in her cerebrospinal fluid and subsequently attained full recovery. Of the limited number of cases that were documented, we report the only case of a patient who was previously immunocompromised to develop the condition. Even though autoimmune encephalitis is an emerging condition, its early differentiation from other causes of encephalitis is crucial in the prognosis of the patient.
Keywords
encephalopathy, nmda, thymoma, autoimmune, receptor, encephalitis, ampa
Published Open-Access
yes
Recommended Citation
Tan, Suyuan; Frade, Heitor; Abdul-Baki, Kian S; et al., "Anti-α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Receptor Antibody Encephalitis in an Immunosuppressed Patient With Myasthenia Gravis Post-thymoma Treatment" (2024). Faculty, Staff and Students Publications. 6282.
https://digitalcommons.library.tmc.edu/baylor_docs/6282